reference/19592793

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19592793

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Randomized Controlled Trial
endingPage	1228
issn	1875-8908 1387-2877
issueIdentifier	4
pageRange	1217-1228
publicationName	Journal of Alzheimer's disease : JAD
startingPage	1217
bibliographicCitation	Nave S, Doody RS, Boada M, Grimmer T, Savola JM, Delmar P, Pauly-Evers M, Nikolcheva T, Czech C, Borroni E, Ricci B, Dukart J, Mannino M, Carey T, Moran E, Gilaberte I, Muelhardt NM, Gerlach I, Santarelli L, Ostrowitzki S, Fontoura P. Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD). J Alzheimers Dis. 2017;58(4):1217–28. PMID: 28550255; PMCID: PMC5523913.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cc92cb948a5b4ef63bc1974f3ec97c8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2f11fc924099e88b5741c6cc1ebb4e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_724e624a335c6381eb1477ff469a3f17 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbbfed51af38e220035b70f29bfc18e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d394882cf3c52fb01e820e50a98465a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba1492c037fd5e07221ef96bc738cf62 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f79130da4716c787844d5f7bed05a403 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59fab7df5538aeaa9333f281846fd418 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b428a69374bd1c400e9dbe88e3e2290d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8580b4fd0f45e56c3216ff172d682df0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd784b89f8b1e6b823ab29c3b40be5c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_399a139f6c806da4308a8d27bae3970a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb172944e1b5fe27a9f7979ba3746b08 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acd2f0d030031c24facf5f4871179e78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c79e9b2088dbcaa489ffc595dc9eda39 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5334690dc217a5f3a0efc2ccd3ee6f9f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7746-0134 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72ed19b02299aaa19606dfae3ed3cb3c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa4aa58f41ed516d54423da39d52a4e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_094eba45f54c6358151700ada32ea647 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c13dfd1435142bf2d559725328cdff3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_930842ad6513ed77bfd265ccc681bddf
date	2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.3233/jad-161309 https://pubmed.ncbi.nlm.nih.gov/28550255 https://pubmed.ncbi.nlm.nih.gov/PMC5523913
isPartOf	https://portal.issn.org/resource/ISSN/1875-8908 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942 https://portal.issn.org/resource/ISSN/1387-2877
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)
discusses	http://id.nlm.nih.gov/mesh/M000627215 http://id.nlm.nih.gov/mesh/M0018278 http://id.nlm.nih.gov/mesh/M0000113 http://id.nlm.nih.gov/mesh/M0021770
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000544Q000188 http://id.nlm.nih.gov/mesh/D011760Q000627 http://id.nlm.nih.gov/mesh/D000081Q000627 http://id.nlm.nih.gov/mesh/D014150Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008279 http://id.nlm.nih.gov/mesh/D000544Q000000981 http://id.nlm.nih.gov/mesh/D006624Q000000981 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D000073216 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_beb86517b90a50474e69aa28f28d04e7 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7404 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10246762 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d911c99a3b86eb938637d11fca0e5d3c http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_971f5dc4b6d2e06a073200edd8457eb6 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_74215c9516abac826539f57c202449f0 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4054 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025

Total number of triples: 72.